MoneyWorks4Me

Lupin informs about investor presentation

12 Feb 2025 Evaluate
Pursuant to Regulation 30(2) read with Schedule III Part A Para A(15)(a)(ii) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Lupin has informed that it enclosed a copy of the Investor Presentation – Q3 FY25.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1745.00
Dr. Reddys Labs. 1242.00
Cipla 1331.00
Lupin 1953.75
Zydus Lifesciences 1113.00
View more..